` MYO (Myomo Inc) vs S&P 500 Comparison - Alpha Spread

MYO
vs
S&P 500

Over the past 12 months, MYO has significantly outperformed S&P 500, delivering a return of 36% compared to the S&P 500's 6% growth.

Stocks Performance
MYO vs S&P 500

Loading

Performance Gap
MYO vs S&P 500

Loading
MYO
S&P 500
Difference

Performance By Year
MYO vs S&P 500

Loading
MYO
S&P 500
Add Stock

Competitors Performance
Myomo Inc vs Peers

Myomo Inc
Glance View

Market Cap
159.9m USD
Industry
Health Care

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.

MYO Intrinsic Value
2.61 USD
Overvaluation 44%
Intrinsic Value
Price
M
Back to Top